Pembrolizumab-Induced Capillary Leak Syndrome: A Rare but Life-Threatening Immune-Related Adverse Event
Open Access
- 21 October 2025
- journal article
- case report
- Published by Springer Nature in Cureus
- Vol. 17 (10) , e95038
Abstract
Capillary leak syndrome (CLS) is an exceptionally rare and potentially life-threatening adverse event characterized by the abrupt shift of intravascular fluid into the extravascular compartment, leading to profound hypotension, edema, and potential multi-organ dysfunction. This condition has been associated with immune checkpoint inhibitors (ICIs) such as pembrolizumab. We present the case of a 67-year-old woman with a history of squamous cell lung carcinoma who underwent four cycles of pembrolizumab and presented multiple times with progressive shortness of breath, anasarca, and dyspnea on exertion. Clinical evaluation ruled out common causes of respiratory compromise and fluid overload, prompting consideration of immune-mediated pathology. Diagnostic studies and clinical evolution supported a diagnosis of CLS, underscoring the importance of early recognition and intervention. This case highlights CLS as a severe but treatable toxicity of pembrolizumab, emphasizing that timely detection and appropriate supportive care are essential for favorable clinical outcomes.Keywords
This publication has 11 references indexed in Scilit:
- Systemic capillary leak syndromeNature Reviews Disease Primers, 2024
- Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary DysfunctionMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2021
- StatPearls2019
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology, 2018
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline SummaryJournal of Oncology Practice, 2018
- Immune-Related Adverse Events Associated with Immune Checkpoint BlockadeNew England Journal of Medicine, 2018
- Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak SyndromeThe American Journal of Medicine, 2017
- Capillary leak syndrome: etiologies, pathophysiology, and managementKidney International, 2017
- The Systemic Capillary Leak Syndrome: A Case Series of 28 Patients From a European RegistryAnnals of Internal Medicine, 2011
- Narrative Review: The Systemic Capillary Leak SyndromeAnnals of Internal Medicine, 2010